Literature DB >> 8359091

Cholestatic hepatitis following flutamide.

A S Rosman1, C Frissora-Rodeo, A T Marshall, B P Reiter, F Paronetto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8359091     DOI： 10.1007/bf01303188

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  6 in total

1.  Flutamide-related fulminant hepatic failure.

Authors:  J C Corkery; W Bihrle; J A McCaffrey; F F Whitcomb; C Levy; R Ellis
Journal:  J Clin Gastroenterol       Date:  1991-06       Impact factor: 3.062

2.  The treatment of advanced prostatic carcinoma with total androgenic blockade using bilateral orchidectomy and flutamide: experience at the National Cancer Institute in Mexico.

Authors:  A Mendoza-Valdés; O Ocampo-del-Carpio; J De-la-Garza
Journal:  Semin Oncol       Date:  1991-10       Impact factor: 4.929

3.  A controlled trial of leuprolide with and without flutamide in prostatic carcinoma.

Authors:  E D Crawford; M A Eisenberger; D G McLeod; J T Spaulding; R Benson; F A Dorr; B A Blumenstein; M A Davis; P J Goodman
Journal:  N Engl J Med       Date:  1989-08-17       Impact factor: 91.245

4.  Flutamide-induced liver failure.

Authors:  S Møller; P Iversen; M B Franzmann
Journal:  J Hepatol       Date:  1990-05       Impact factor: 25.083

5.  The pharmacokinetics of flutamide and its major metabolites after a single oral dose and during chronic treatment.

Authors:  M Schulz; A Schmoldt; F Donn; H Becker
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

6.  Incidence of liver toxicity associated with the use of flutamide in prostate cancer patients.

Authors:  J L Gomez; A Dupont; L Cusan; M Tremblay; R Suburu; M Lemay; F Labrie
Journal:  Am J Med       Date:  1992-05       Impact factor: 4.965
  6 in total
  5 in total

Review 1.  How actual is the treatment with antiandrogen alone in patients with polycystic ovary syndrome?

Authors:  E Diamanti-Kandarakis
Journal:  J Endocrinol Invest       Date:  1998-10       Impact factor: 4.256

2.  Flutamide attenuates pro-inflammatory cytokine production and hepatic injury following trauma-hemorrhage via estrogen receptor-related pathway.

Authors:  Tomoharu Shimizu; Huang-Ping Yu; Ya-Ching Hsieh; Mashkoor A Choudhry; Takao Suzuki; Kirby I Bland; Irshad H Chaudry
Journal:  Ann Surg       Date:  2007-02       Impact factor: 12.969

3.  Flutamide-induced toxic hepatitis. Potential utility of ursodeoxycholic acid administration in toxic hepatitis.

Authors:  C Cicognani; M Malavolti; A M Morselli-Labate; C Sama; L Barbara
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

Review 4.  [Toxic hepatitis and liver failure under therapy with flutamide].

Authors:  C Lübbert; M Wiese; R Haupt; B R Ruf
Journal:  Internist (Berl)       Date:  2004-03       Impact factor: 0.743

5.  Flutamide-induced cytotoxicity and oxidative stress in an in vitro rat hepatocyte system.

Authors:  Abdullah Al Maruf; Peter O'Brien
Journal:  Oxid Med Cell Longev       Date:  2014-10-13       Impact factor: 6.543
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.